» Articles » PMID: 37507968

Oxidative Stress in Obstructive Sleep Apnea Syndrome: Putative Pathways to Hearing System Impairment

Abstract

Introduction: OSAS is a disease that affects 2% of men and 4% of women of middle age. It is a major health public problem because untreated OSAS could lead to cardiovascular, metabolic, and cerebrovascular complications. The more accepted theory relates to oxidative stress due to intermittent hypoxia, which leads, after an intense inflammatory response through multiple pathways, to endothelial damage. The objective of this study is to demonstrate a correlation between OSAS and hearing loss, the effect of the CPAP on hearing function, and if oxidative stress is also involved in the damaging of the hearing system.

Methods: A review of the literature has been executed. Eight articles have been found, where seven were about the correlation between OSAS and the hearing system, and only one was about the CPAP effects. It is noted that two of the eight articles explored the theory of oxidative stress due to intermittent hypoxia.

Results: All studies showed a significant correlation between OSAS and hearing function ( < 0.05).

Conclusions: Untreated OSAS affects the hearing system at multiple levels. Oxidative stress due to intermittent hypoxia is the main pathogenetic mechanism of damage. CPAP has no effects (positive or negative) on hearing function. More studies are needed, with the evaluation of extended high frequencies, the execution of vocal audiometry in noisy environments, and the evaluation of potential biomarkers due to oxidative stress.

Citing Articles

Combined exposure to mixed brominated flame retardants on obstructive sleep apnea syndrome in US adults.

Liu J, Liu Z, Liu X, Wang N, Wu L, Xu X BMC Public Health. 2025; 25(1):146.

PMID: 39806355 PMC: 11730165. DOI: 10.1186/s12889-024-21204-2.


The relationships between intermittent hypoxia and oxidative stress in patients with sleep apnea syndrome.

Tokunou T, Yoshikawa T, Yoshioka Y, Ando S Sleep Biol Rhythms. 2024; 22(4):499-504.

PMID: 39300984 PMC: 11408442. DOI: 10.1007/s41105-024-00537-w.


Exploring the bidirectional relationship between sleep disorders and atrial fibrillation: implications for risk stratification and management.

Ogieuhi I, Ugiomoh O, Awe M, Khan M, Kwape J, Akpo D Egypt Heart J. 2024; 76(1):95.

PMID: 39080107 PMC: 11289190. DOI: 10.1186/s43044-024-00524-z.


Exploring the interplay of depression, sleep quality, and hearing in tinnitus-related handicap: insights from polysomnography and pure-tone audiometry.

Chang T, Yao Y, Hsu C, Yen T BMC Psychiatry. 2024; 24(1):459.

PMID: 38898451 PMC: 11186200. DOI: 10.1186/s12888-024-05912-y.


Mendelian Randomization Reveals: Triglycerides and Sensorineural Hearing Loss.

Ding S, Liu Y, Duan T, Fang P, Tong Q, Li H Bioengineering (Basel). 2024; 11(5).

PMID: 38790305 PMC: 11118253. DOI: 10.3390/bioengineering11050438.


References
1.
Sadasivam K, Patial K, Vijayan V, Ravi K . Anti-oxidant treatment in obstructive sleep apnoea syndrome. Indian J Chest Dis Allied Sci. 2011; 53(3):153-62. View

2.
Akinnusi M, Jaoude P, Kufel T, El-Solh A . Toll-like receptor activity in patients with obstructive sleep apnea. Sleep Breath. 2012; 17(3):1009-16. DOI: 10.1007/s11325-012-0791-2. View

3.
Kezirian E, Hohenhorst W, de Vries N . Drug-induced sleep endoscopy: the VOTE classification. Eur Arch Otorhinolaryngol. 2011; 268(8):1233-1236. DOI: 10.1007/s00405-011-1633-8. View

4.
Deniz M, Ersozlu T . Evaluation of the changes in the hearing system over the years among patients with OSAS using a CPAP device. Cranio. 2020; 40(6):524-527. DOI: 10.1080/08869634.2020.1783050. View

5.
Patt B, Jarjoura D, Haddad D, Sen C, Roy S, Flavahan N . Endothelial dysfunction in the microcirculation of patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2010; 182(12):1540-5. PMC: 3029939. DOI: 10.1164/rccm.201002-0162OC. View